Email ID
Password
Sign me in automatically next time
Scrip Regulatory Affairs
US FDA considers new labelling policy for home-use devices
23 April 2010
Vibha Sharma, Bernard Murphy

The US Food and Drug Administration has launched a new initiative aimed at assuring the safe use of medical devices in patients’ homes1.

With the ageing of the US population and shifts towards shorter hospital stays, the FDA points out that a significant number of medical devices – including haemodialysis equipment, infusion pumps, ventilators and wound care therapies – are now being used in homes...

Please login to read the full article.
 
 
 
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
   
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36